Global Healthcare Strategy Consulting Expert Sheldon Ng Joins Navigant to Bolster Life Sciences and Provider Collaboration

Ng will further enable strategic engagements between
biopharmaceutical and medical technology companies and health systems

CHICAGO–(BUSINESS WIRE)–lt;a href=”https://twitter.com/search?q=%24NCI&src=ctag” target=”_blank”gt;$NCIlt;/agt;–Navigant (NYSE: NCI) today announced that Sheldon Ng has joined the firm
as a managing director in its life sciences practice. In this role, Ng
will lead Navigant’s San Francisco-based life sciences strategy
consulting team and spearhead the firm’s center of excellence focused on
supporting biopharmaceutical and medical technology strategic
partnerships with health systems.

“Today’s highly specialized and complex healthcare ecosystem requires
pharmaceutical and medical device companies to seek new insights and
methodologies to help answer critical business questions,” said Eduardo
Schur, managing director and leader of Navigant’s global life sciences
practice. “Sheldon’s depth of expertise will further our commitment to
advancing multi-stakeholder partnerships among our provider, payer, and
life sciences clients to the benefit of patients worldwide.”

Ng brings nearly two decades of experience partnering with emerging and
established biopharmaceutical and medical technology companies in areas
such as intelligent personalized healthcare, value-based solutions, and
strategic account management. He previously served as the vice president
of strategy and analytics at Locust Walk, where he launched a practice
to accelerate partnering and financing life sciences transactions.
Previously, Ng led the commercial strategy practice for Health Advances
and was head of Promidian’s San Francisco office, where he was
responsible for establishing its West Coast business. Ng also held
commercial and scientific leadership positions at IQVIA (formerly IMS
Consulting Group), Hana Biosciences, Guava Technologies, Exelixis, and
Chiron.

Navigant’s
life sciences practice
is comprised of specialized consultants,
former pharmaceutical and medical technology executives, clinicians,
researchers, and other experts with decades of strategy, operational
consulting, compliance, regulatory, and reimbursement services
experience. Professionals collaborate with life sciences clients, as
well as hospitals and health systems, physician enterprises, payers, and
government, to provide strategic management solutions. Navigant’s life
sciences practice is a part of the firm’s Healthcare segment.

About Navigant

Navigant Consulting, Inc. (NYSE: NCI) is a specialized, global
professional services firm that helps clients take control of their
future. Navigant’s professionals apply deep industry knowledge,
substantive technical expertise, and an enterprising approach to help
clients build, manage, and/or protect their business interests. With a
focus on markets and clients facing transformational change and
significant regulatory or legal pressures, the firm primarily serves
clients in the healthcare, energy, and financial services industries.
Across a range of advisory, consulting, outsourcing, and
technology/analytics services, our practitioners bring sharp insight
that pinpoints opportunities and delivers powerful results. More
information about Navigant can be found at navigant.com.

Contacts

Kyle Bland
Navigant Investor Relations
312.573.5624
[email protected]

Alven Weil
Navigant
704.995.5607
[email protected]

error: Content is protected !!